| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/1997 | WO1997031907A1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/04/1997 | WO1997031906A1 Isoxazole derivatives |
| 09/04/1997 | WO1997031903A1 Azole compounds endowed with antimycotic activity for human and veterinary use |
| 09/04/1997 | WO1997031902A1 Quinoxaline derivatives useful in therapy |
| 09/04/1997 | WO1997031901A1 Hydroxyhexahydropyridazines |
| 09/04/1997 | WO1997031899A1 Synthetic derivatives of rapamycin as multimerising agents for chimeric proteins with immunophilin derived domains |
| 09/04/1997 | WO1997031898A1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 09/04/1997 | WO1997031897A1 Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031893A1 Process for scavenging thiols |
| 09/04/1997 | WO1997031887A1 Aminotetralin derivatives and compositions and method of use thereof |
| 09/04/1997 | WO1997031709A1 Antimicrobial compositions |
| 09/04/1997 | WO1997031657A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | WO1997031655A2 Modified cytokines for therapeutic use |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031645A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/04/1997 | WO1997031643A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 09/04/1997 | WO1997031642A1 Anti-hiv agent |
| 09/04/1997 | WO1997031641A1 Method of treating hepatitis delta virus infection |
| 09/04/1997 | WO1997031640A1 Combination therapy for osteoporosis |
| 09/04/1997 | WO1997031639A1 TABLETS CONTAINING β-LACTAM ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME |
| 09/04/1997 | WO1997031638A1 USE OF α1-ADRENOCEPTOR ANTAGONISTS |
| 09/04/1997 | WO1997031637A1 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | WO1997031635A1 Methods of treating or preventing sleep apnea |
| 09/04/1997 | WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis |
| 09/04/1997 | WO1997031633A1 Methods of treating or preventing sleep apnea |
| 09/04/1997 | WO1997031631A1 Cox-2 selective inhibitors for managing labour and uterine contractions |
| 09/04/1997 | WO1997031630A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
| 09/04/1997 | WO1997031629A1 Treatment of sleep disorders |
| 09/04/1997 | WO1997031628A1 Peptidomimetics for the treatment of hiv infection |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | WO1997031621A1 Delivery system for localized administration of medicaments to the upper respiratory tract |
| 09/04/1997 | WO1997031611A2 Treatment of begnin prostatic hyperplasia |
| 09/04/1997 | WO1997031546A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | WO1997031533A1 Antimicrobial composition, particularly for antisepsis and/or disinfection |
| 09/04/1997 | WO1997031531A1 Antiandrogenic agents and methods of identification thereof |
| 09/04/1997 | WO1997031530A1 Novel antimicrobial activity of gemfibrozil |
| 09/04/1997 | WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 09/04/1997 | WO1997016457A3 Anti-tumoral protein |
| 09/04/1997 | DE19607487A1 Verwendung von alpha1-Adrenoceptor-Antagonisten Use of alpha1-adrenoceptor antagonists |
| 09/04/1997 | DE19607395A1 Morphin- und Diamorphinsalze anionischer nicht-narkotischer Analgetika vom Typ der substituierten Carbonsäuren, Verfahren zu deren Herstellung, deren Verwendung und die diese Salze enthaltenden pharmazeutischen Präparate Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their preparation, their use and the pharmaceutical preparations containing these salts |
| 09/04/1997 | CA2248269A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | CA2247901A1 Proton pump inhibitor |
| 09/04/1997 | CA2247899A1 Process for scavenging thiols |
| 09/04/1997 | CA2247439A1 Isoxazole derivatives |
| 09/04/1997 | CA2247438A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/04/1997 | CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | CA2247390A1 Azole compounds endowed with antimycotic activity for human and veterinary use |
| 09/04/1997 | CA2247370A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
| 09/04/1997 | CA2247308A1 Modified cytokines for therapeutic use |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2247138A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2246756A1 Fibrinogen receptor antagonists |
| 09/04/1997 | CA2246722A1 Serine protease inhibitors |
| 09/04/1997 | CA2246246A1 Serine protease inhibitors |
| 09/04/1997 | CA2245932A1 Pharmaceutical compounds |
| 09/04/1997 | CA2245871A1 Treatment of sleep disorders |
| 09/04/1997 | CA2244219A1 Isoquinolines useful as analgesics |
| 09/04/1997 | CA2243243A1 Aminotetralin derivatives and compositions and method of use thereof |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/04/1997 | CA2198979A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792885A2 Derivatives of 12,13-epoxy-tylosin and processes of manufacture thereof |
| 09/03/1997 | EP0792883A1 Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them |
| 09/03/1997 | EP0792879A1 Hydrate for medicinal use |
| 09/03/1997 | EP0792878A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 09/03/1997 | EP0792874A1 Quinoxaline derivatives useful in therapy |
| 09/03/1997 | EP0792873A1 N-(Phenoxyalkyl) carboxamides and their use as antiarrhythmic agents |
| 09/03/1997 | EP0792649A1 Treatment of sleep disorders |
| 09/03/1997 | EP0792648A2 Pharmaceutical composition containing hirudin and process for its preparation |
| 09/03/1997 | EP0792647A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/03/1997 | EP0792645A1 Combination therapy to treat osteoporosis |
| 09/03/1997 | EP0792644A1 Aqueous eye drops containing apafant as principal agent |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792642A1 Method of treating conditions with estrogen agonists |
| 09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
| 09/03/1997 | EP0792639A1 Combination therapy to treat osteoporosis or conditions which present low bone mass |
| 09/03/1997 | EP0792638A1 Use of 1,1,2-triphenylbut-1-ene derivatives for the manufacture of a medicament for treating Alzheimer's disease |
| 09/03/1997 | EP0792371A1 Combination method for acne treatment |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792350A1 Regulation of neural stem cell proliferation |
| 09/03/1997 | EP0792289A1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792273A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials |
| 09/03/1997 | EP0792271A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum |
| 09/03/1997 | EP0792270A1 Natriuretic cyclic compounds |
| 09/03/1997 | EP0792269A2 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 09/03/1997 | EP0792268A1 Hypolipidemic benzothiazepines |
| 09/03/1997 | EP0792265A1 Endothelin antagonists |
| 09/03/1997 | EP0792264A1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
| 09/03/1997 | EP0792163A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 09/03/1997 | EP0792154A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 09/03/1997 | EP0792153A1 Compositions containing lazaroids and their use for preventing adhesions |
| 09/03/1997 | EP0792152A1 Compositions and methods for contraception and for treatment of benign gynecological disorders |
| 09/03/1997 | EP0792151A2 Use of substituted aryl-morpholino-, thiomorpholino- or piperazino-propanones for the treatement of prevention of alzheimer'disease |
| 09/03/1997 | EP0792150A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/03/1997 | EP0792149A2 Oral compositions containing ondansetron |